APA

Ma L., Clayton J. R., Walgren R. A., Zhao B., Evans R. J., Smith M. C., Heinz-Taheny K. M., Kreklau E. L., Bloem L., Pitou C., Shen W., Strelow J. M., Halstead C., Rempala M. E., Parthasarathy S., Gillig J. R., Heinz L. J., Pei H., Wang Y., Stancato L. F., Dowless M. S., Iversen P. W. & Burkholder T. P. (20130416). Discovery and characterization of LY2784544, a small-molecule tyrosine kinase inhibitor of JAK2V617F. : Blood cancer journal.

Chicago

Ma L, Clayton J R, Walgren R A, Zhao B, Evans R J, Smith M C, Heinz-Taheny K M, Kreklau E L, Bloem L, Pitou C, Shen W, Strelow J M, Halstead C, Rempala M E, Parthasarathy S, Gillig J R, Heinz L J, Pei H, Wang Y, Stancato L F, Dowless M S, Iversen P W and Burkholder T P. 20130416. Discovery and characterization of LY2784544, a small-molecule tyrosine kinase inhibitor of JAK2V617F. : Blood cancer journal.

Harvard

Ma L., Clayton J. R., Walgren R. A., Zhao B., Evans R. J., Smith M. C., Heinz-Taheny K. M., Kreklau E. L., Bloem L., Pitou C., Shen W., Strelow J. M., Halstead C., Rempala M. E., Parthasarathy S., Gillig J. R., Heinz L. J., Pei H., Wang Y., Stancato L. F., Dowless M. S., Iversen P. W. and Burkholder T. P. (20130416). Discovery and characterization of LY2784544, a small-molecule tyrosine kinase inhibitor of JAK2V617F. : Blood cancer journal.

MLA

Ma L, Clayton J R, Walgren R A, Zhao B, Evans R J, Smith M C, Heinz-Taheny K M, Kreklau E L, Bloem L, Pitou C, Shen W, Strelow J M, Halstead C, Rempala M E, Parthasarathy S, Gillig J R, Heinz L J, Pei H, Wang Y, Stancato L F, Dowless M S, Iversen P W and Burkholder T P. Discovery and characterization of LY2784544, a small-molecule tyrosine kinase inhibitor of JAK2V617F. : Blood cancer journal. 20130416.